Pioneering doctor reflects on gene therapy’s trajectory
November 23, 2016
“There were a lot of expectations 20 years ago, then there was a big drop related to side effects,” Alessandra Biffi, MD, director of gene therapy at Dana-Farber/Boston Children’s, tells New Scientist.
“Now everybody is again climbing to the top of the hill. But whether there is too much or too little enthusiasm doesn’t change the fact that development of gene therapy as a treatment is a process.”